Cancer Biology at HD Biosciences offers a full-spectrum of high quality, timely and cost-effective oncology drug discovery, predictive biomarker, companion diagnostics discovery and preclinical development services. These include target identification and validation, in vitro cell based assays and screening, in vivo tumor modeling, in vivo pharmacology, PK/PD and exploratory toxicology. We also offer in-depth mechanism of action studies and support translational predictive biomarker development. Leveraging our cutting-edge technology, we have built a comprehensive platform for Immuno-Oncology drug discovery